HomeCMRA • OTCMKTS
add
Comera Life Sciences Holdings Inc
Previous close
$0.00
Market cap
30.00 USD
Avg Volume
1.48K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Revenue | 136.31K | -41.98% |
Operating expense | 2.25M | -16.90% |
Net income | -2.15M | 30.00% |
Net profit margin | -1.58K | -20.64% |
Earnings per share | — | — |
EBITDA | -2.13M | 15.03% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.77M | -33.77% |
Total assets | 3.07M | -37.78% |
Total liabilities | 2.97M | -24.50% |
Total equity | 102.26K | — |
Shares outstanding | 30.74M | — |
Price to book | -0.00 | — |
Return on assets | -199.28% | — |
Return on capital | 5,690.16% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Net income | -2.15M | 30.00% |
Cash from operations | -1.91M | 19.90% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 3.21M | 2,108.29% |
Net change in cash | 1.29M | 156.91% |
Free cash flow | -1.35M | 48.44% |
About
Founded
2014
Headquarters
Website
Employees
13
